This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Factor X Deficiency
and you are
over 12
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The main objective of the study is to assess the pharmacokinetics of FACTOR X after a single dose of 25IU/kg. The secondary objectives of the study are to assess efficacy and safety of FACTOR X in the treatment of bleeding episodes over at least 6 months.

Provided treatments

  • Biological: Human Coagulation FACTOR X
Tris trial is registered with FDA with number: NCT00930176. The sponsor of the trial is Bio Products Laboratory and it is looking for 16 volunteers for the current phase.
Official trial title:
A Phase III Open, Multicentre Study to Investigate the Pharmacokinetics, Safety and Efficacy of BPL's High Purity Factor X in the Treatment of Severe and Moderate Factor X Deficiency.